Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Novartis claims sLe(x)/sLe(a) mimetics

Feb. 28, 1997

Selectin inhibitors from TBC

Feb. 27, 1997

MMP inhibitors synthesized by Otsuka

Feb. 27, 1997

Zeneca discloses agents for pain associated with inflammation

Feb. 25, 1997

Immunex clones and describes target for RA

Feb. 21, 1997

Relaxin-like factor and relaxin analogues described

Feb. 21, 1997

Akzo reports peptides for specific tolerance therapy

Feb. 20, 1997

SKB prepares cytokine inhibitors

Feb. 19, 1997

University of California researchers report pseudopterosin derivatives

Feb. 19, 1997

Inhibitors of cell adhesion disclosed by Tanabe

Feb. 18, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...